PhotoPharmics Announces Publication of Phase 2 Clinical Trial Results in Neurotherapeutics

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...
Fierce Biotech

Upstream posts Tezspire-like asthma efficacy in phase 2 but falls short of best-case scenario

A phase 2 asthma study of Upstream Bio’s TSLP receptor agonist has hit its primary endpoint. But with only the 12-week ...
Fierce Biotech

AstraZeneca reveals oral GLP-1 scored phase 2 wins but holds back weight loss data

AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining ...
BioSpace

Kailera, Hengrui Push Oral GLP-1/GIP Pill to Phase 3 After Clearing Mid-Stage China Study

Kailera will launch a global Phase 2 study of ribupatide this year, while Hengrui will push the asset into Phase 3 in China.
EurekAlert!

Landmark Phase II study in platinum-resistant ovarian cancer to be presented at ESGO 2026

Study to be presented at this year's ESGO 2026 , demonstrates significant overall survival benefit with Elenagen plus ...